COMMUNIQUÉS West-GlobeNewswire
-
Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026
06/08/2026 -
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
06/08/2026 -
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
06/08/2026 -
Sharecare launches AskMD nationwide to turn any health question into a personalized plan
06/08/2026 -
Kyntra Bio to Report Second Quarter 2026 Financial Results
06/08/2026 -
Alpha Pro Tech, Ltd. Announces Second Quarter 2026 Financial Results
06/08/2026 -
Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside
06/08/2026 -
Sonablate Announces Landmark Global Strategic Alliance with Eleven Ventures to Advance AI-Powered Precision Medicine
06/08/2026 -
Spirited Paw® Healthy Mind By Standard Process® Named 2026 Senior Dog Nutrition Product of the Year
06/08/2026 -
Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026
06/08/2026 -
Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update
06/08/2026 -
IBA : Publication des résultats du premier semestre 2026 et conférence web
06/08/2026 -
IBA Notice of Half Year 2026 Results and Conference Call
06/08/2026 -
Actimed Therapeutics Reacquires Global Rights to S-oxprenolol, Broadening Pipeline Opportunity
06/08/2026 -
ARCPOINT ANNOUNCES FAILURE-TO-FILE CEASE TRADE ORDER
06/08/2026 -
Braveheart Bio Announces Pricing of Upsized Initial Public Offering
06/08/2026 -
UPDATE - LifeMD Reports Second Quarter 2026 Results
06/08/2026 -
CellFiber and Tidewave Bio Enter Collaboration to Evaluate Scalable 3D Manufacturing for Next-Generation Solid Tumor Immunotherapy
06/08/2026 -
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
06/08/2026
Pages